Urinary Incontinence Devices Market

By Product;

Urinary Catheters - [Foley Catheters & Other],and Vaginal Slings - [Conventional Vaginal Slings & Advanced Vaginal Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Other Devices]

By Incontinence Type;

Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Urinary Incontinence, and Functional Urinary Incontinence

By Category;

Internal Incontinence Devices and External Incontinence Devices

By End User;

Hospitals, Clinics, and Other

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn115596626 Published Date: August, 2025

Urinary Incontinence Devices Market Overview

Urinary Incontinence Devices Market (USD Million)

Urinary Incontinence Devices Market was valued at USD 5,522.11 million in the year 2024. The size of this market is expected to increase to USD 10,101.13 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.0%.


Urinary Incontinence Devices Market

*Market size in USD million

CAGR 9.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.0 %
Market Size (2024)USD 5,522.11 Million
Market Size (2031)USD 10,101.13 Million
Market ConcentrationMedium
Report Pages350
5,522.11
2024
10,101.13
2031

Major Players

  • Boston Scientific Corporation
  • Caldera Medical
  • Cogentix Medical Inc
  • Coloplast A/S
  • ConvaTec Healthcare B S..r.l
  • Cook Medical
  • C.R. Bard Inc
  • Johnson & Johnson (Ethicon Inc.)
  • Medtronic Plc. (Covidien Ltd.)
  • ProSurg Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Urinary Incontinence Devices Market

Fragmented - Highly competitive market without dominant players


The Urinary Incontinence Devices Market is rapidly evolving as more individuals seek effective and reliable continence care solutions. With nearly 55% of patients choosing non-invasive technologies, the sector is benefiting from a strong shift toward user-centric innovations. Enhanced awareness around the impact of early management is creating vast opportunities for advancement and growth. Technological progress continues to deliver more accessible and patient-friendly devices that improve daily living standards.

Strategic Collaborations and Partnerships
More than 50% of device manufacturers are engaged in mergers, partnerships, and collaborative initiatives aimed at strengthening product lines and market reach. These strategies help in integrating advanced functionalities and broadening the appeal of devices across medical settings. Through streamlined approvals and combined expertise, such efforts are speeding up market accessibility and ensuring competitive differentiation.

Rising Demand and Market Opportunities
With nearly 65% of affected individuals seeking reliable interventions, the demand for customized and minimally invasive urinary incontinence devices continues to rise. This surge is unlocking new opportunities for specialized product innovation and broader treatment accessibility. Focused on cost efficiency and clinical dependability, manufacturers are aligning their strategies to address unmet healthcare needs.

Future Outlook and Expansion Potential
The growing link between aging demographics, lifestyle-related conditions, and incontinence is shaping a promising future outlook for the market. Over 58% of providers now incorporate advanced devices into routine care, signaling widespread adoption. Sustained efforts in product diversification, technology integration, and clinical validation are setting the stage for long-term growth and strategic expansion across the healthcare continuum.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Incontinence Type
    3. Market Snapshot, By Category
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Urinary Incontinence Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Awareness and Acceptance
        2. Favorable Reimbursement Policies
        3. Lifestyle Changes and Urbanization
      2. Restraints
        1. Regulatory Hurdles
        2. Limited Awareness in Developing Regions
        3. Alternative Treatment Options
      3. Opportunities
        1. Telemedicine and Remote Monitoring
        2. Strategic Partnerships and Collaborations
        3. Focus on Patient Education and Support
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Urinary Incontinence Devices Market, By Product, 2021- 2031(USD Million)
      1. Urinary Catheters
        1. Foley Catheters
        2. Other
      2. Vaginal Slings
        1. Conventional Vaginal Slings
        2. Advanced Vaginal Slings
        3. Electrical Stimulation Devices
        4. Artificial Urinary Sphincters
        5. Other Devices
    2. Urinary Incontinence Devices Market, By Incontinence Type, 2021- 2031(USD Million)
      1. Stress Urinary Incontinence
      2. Urge Urinary Incontinence
      3. Overflow Urinary Incontinence
      4. Functional Urinary Incontinence
    3. Urinary Incontinence Devices Market, By Category, 2021- 2031(USD Million)
      1. Internal Incontinence Devices
      2. External Incontinence Devices
    4. Urinary Incontinence Devices Market, By End User, 2021- 2031(USD Million)
      1. Hospitals
      2. Clinics
      3. Other
    5. Urinary Incontinence Devices Market, By Geography, 2021- 2031(USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific Corporation
      2. Caldera Medical
      3. Cogentix Medical Inc
      4. Coloplast A/S
      5. ConvaTec Healthcare B S..r.l
      6. Cook Medical
      7. C.R. Bard Inc
      8. Johnson & Johnson (Ethicon Inc.)
      9. Medtronic Plc. (Covidien Ltd.)
      10. ProSurg Inc
  7. Analyst Views
  8. Future Outlook of the Market